Thyroid problems in people with low platelets
Part of Blood & lymphatic, Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at whether having thyroid problems is common in people with ITP and if it affects how well ITP treatments work. By joining, you might help doctors understand this link and improve care for others.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ITP, a condition with low blood platelets.
- You are either newly diagnosed, have had ITP for a while, or treatments haven't worked well.
- You have not had your thyroid gland removed.
- Your ITP was not caused by a medication.
- You do not have hepatitis C, hepatitis B, or HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood test antibodies to help confirm whether low platelet counts are caused by an autoimmune condition. It may help doctors better classify your type of low platelets and guide appropriate next steps.
This study tests drugs called thrombopoietin agonists to help raise platelet levels in adults with ITP. It may help reduce bleeding risk and improve daily life.
This study tests whether adding another medicine (telitacicept) to a standard platelet-boosting drug (eltrombopag) works better than eltrombopag alone for adults with ITP that hasn't improved with steroids. The goal is to help raise your platelet counts and reduce bleeding risk.
This study looks at whether chronic or persistent immune thrombocytopenia (ITP) affects thinking and memory. If you have had low platelet counts for 3 months or more and have been treated for ITP, you may help researchers understand how the condition can impact the brain.
This trial studies whether “TPO” medicines (like eltrombopag or similar drugs) help people age 14 and older with primary immune thrombocytopenia (ITP) who did not respond well to first treatments. It may help raise platelet counts and reduce bleeding, especially when prior therapy hasn’t worked.
This study looks at levels of two proteins (interleukin-1β and interleukin-33) in your blood to better understand and tell apart two conditions that cause low platelets. It may help doctors improve diagnosis and treatment for people with these conditions.
Hear when a new Immune Thrombocytopenic Purpura trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.